microRNA expression changes after atrial fibrillation catheter ablation (Q38629524)

4 September 2017

microRNA expression changes after atrial fibrillation catheter ablation (English)

1 reference

4 September 2017

0 references

0 references

0 references

1 reference

3

1 reference

4 September 2017

Celestino Sardu

1

1 reference

PubMed ID

26554530

4 September 2017

Matteo Santamaria

series ordinal

2

1 reference

PubMed ID

26554530

4 September 2017

Raffaele Marfella

series ordinal

4

1 reference

4 September 2017

10 November 2015

1 reference

4 September 2017

1 reference

4 September 2017

16

1 reference

4 September 2017

1863-1877

1 reference

4 September 2017

16

1 reference

Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning

4 September 2017

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Recent advances in the molecular pathophysiology of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Remodelling of gap junctions and connexin expression in diseased myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Gap junction alterations in human cardiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Loss of microRNA-106b-25 cluster promotes atrial fibrillation by enhancing ryanodine receptor type-2 expression and calcium release.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Déjà vu in the theories of atrial fibrillation dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Atrial remodeling and atrial fibrillation: mechanisms and implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Statins and polyunsaturated fatty acids for treatment of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Is cryoballoon ablation preferable to radiofrequency ablation for treatment of atrial fibrillation by pulmonary vein isolation? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Plasma microRNAs are associated with atrial fibrillation and change after catheter ablation (the miRhythm study).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

The Caenorhabditis elegans heterochronic gene lin-14 encodes a nuclear protein that forms a temporal developmental switch

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

The shaping and functional consequences of the microRNA landscape in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Transcription and processing of human microRNA precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA biogenesis: coordinated cropping and dicing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Atrial fibrillation and microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Phosphoinositide 3-kinase (PI3K(p110alpha)) directly regulates key components of the Z-disc and cardiac structure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA-1 accelerates the shortening of atrial effective refractory period by regulating KCNE1 and KCNB2 expression: an atrial tachypacing rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Role of miR-21 in the pathogenesis of atrial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Inhibition of miR-25 improves cardiac contractility in the failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Biventricular pacing cardiac contractility modulation improves cardiac contractile function via upregulating SERCA2 and miR-133 in a rabbit model of congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA-133 modulates the β1-adrenergic receptor transduction cascade.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Rapid and slow components of delayed rectifier current in human atrial myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

KCNQ1 gain-of-function mutation in familial atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA-150 regulates the cytotoxicity of natural killers by targeting perforin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA-150 aggravates H2O2-induced cardiac myocyte injury by down-regulating c-myb gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Relation of reduced expression of MiR-150 in platelets to atrial fibrillation in patients with chronic systolic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Atrial remodeling in atrial fibrillation and some related microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Atrial fibrillation: recent advances in understanding the role of microRNAs in atrial remodeling with an electrophysiological overview

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

The association between circulating microRNA levels and coronary endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

miR-543 and miR-590-3p regulate human mesenchymal stem cell aging via direct targeting of AIMP3/p18

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Inhibitory effect of hsa-miR-590-5p on cardiosphere-derived stem cells differentiation through downregulation of TGFB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Mean platelet volume in patients with nonvalvular atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Functional role of miRNA in cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Delayed Cell Cycle Progression in STHdh(Q111)/Hdh(Q111) Cells, a Cell Model for Huntington's Disease Mediated by microRNA-19a, microRNA-146a and microRNA-432.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Novel molecular targets for atrial fibrillation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

A selective microRNA-based strategy inhibits restenosis while preserving endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Development of microRNA therapeutics is coming of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Treatment of HCV infection by targeting microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.117

21 January 2018

Identifiers

DOI

10.2217/PGS.15.117

1 reference

4 September 2017

1 reference

PubMed ID

26554530